Skip to Main Content

Author Details

Richard K G Do
Memorial Sloan Kettering Cancer Center
1996
167
44
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
38006509Quantitation of Oncologic Image Features for Radiomic Analyses in PET.Methods Mol Biol2024
35920706Hepatic Adenoma Subtypes on Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI: Systematic Review and Meta-Analysis.AJR Am J Roentgenol2023
37769223Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced Hepatocellular Carcinoma.JCO Precis Oncol2023
37174039Artificial Intelligence in CT and MR Imaging for Oncological Applications.Cancers (Basel)2023
37406106Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric Cancer.Clin Cancer Res2023
37274758Registration-based biomarkers for neoadjuvant treatment response of pancreatic cancer via longitudinal image registration.J Med Imaging (Bellingham)2023
37165196Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer.Nature2023
37027632Computerized Diagnosis of Liver Tumors From CT Scans Using a Deep Neural Network Approach.IEEE J Biomed Health Inform2023
36853182LI-RADS: Looking Back, Looking Forward.Radiology2023
36918130Phase 1 Dose Escalation Study of SBRT Using 3 Fractions for Locally Advanced Pancreatic Cancer.Int J Radiat Oncol Biol Phys2023
36848609Precision Management of a Patient With Dihydropyrimidine Dehydrogenase Deficiency and Liver-Predominant Metastatic Rectal Cancer Using Hepatic Arterial Floxuridine.JCO Precis Oncol2023
36396457Interim Analysis of a Prospective Validation of 2 Blood-Based Genomic Assessments (PPQ and NETest) to Determine the Clinical Efficacy of <sup>177</sup>Lu-DOTATATE in Neuroendocrine Tumors.J Nucl Med2023
36872608Updates on LI-RADS Treatment Response Criteria for Hepatocellular Carcinoma: Focusing on MRI.J Magn Reson Imaging2023
36598414Reply to "Hepatic Adenomas With Hepatobiliary Phase Iso- or Hyperintensity: Standardized Definitions Are Required".AJR Am J Roentgenol2023
36241752Postoperative surveillance of pancreatic ductal adenocarcinoma (PDAC) recurrence: practice pattern on standardized imaging and reporting from the society of abdominal radiology disease focus panel on PDAC.Abdom Radiol (NY)2023
36305619GRASPNET: Fast spatiotemporal deep learning reconstruction of golden-angle radial data for free-breathing dynamic contrast-enhanced magnetic resonance imaging.NMR Biomed2023
32962925Risk Factors for Hypervascularization in Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement: A Systematic Review and Meta-analysis.Acad Radiol2022
35840566The Medical Segmentation Decathlon.Nat Commun2022
35609558Treatment Response and Clinical Outcomes of Well-Differentiated High-Grade Neuroendocrine Tumors to Lutetium-177-DOTATATE.Neuroendocrinology2022
35366706Recurrence After Resection of Pancreatic Cancer: Can Radiomics Predict Patients at Greatest Risk of Liver Metastasis?Ann Surg Oncol2022
35596777Gender and racial diversity among plenary session speakers at the Society of Abdominal Radiology Annual Meetings: a five-year assessment.Abdom Radiol (NY)2022
35389052Liver imaging: it is time to adopt standardized terminology.Eur Radiol2022
35657292Standardized Reporting of Oncologic Response: Making Every Report Count.Radiol Imaging Cancer2022
36103642Natural Language Processing of Computed Tomography Reports to Label Metastatic Phenotypes With Prognostic Significance in Patients With Colorectal Cancer.JCO Clin Cancer Inform2022
35283010Machine learning radiomics can predict early liver recurrence after resection of intrahepatic cholangiocarcinoma.HPB (Oxford)2022
35310959Developing a Cancer Digital Twin: Supervised Metastases Detection From Consecutive Structured Radiology Reports.Front Artif Intell2022
34990210Natural Language Processing of Large-Scale Structured Radiology Reports to Identify Oncologic Patients With or Without Splenomegaly Over a 10-Year Period.JCO Clin Cancer Inform2022
35193080Incidental liver lesions on baseline breast MRI: Outcomes on subsequent abdominal imaging.Clin Imaging2022
34825946A primer on texture analysis in abdominal radiology.Abdom Radiol (NY)2022
34644607LI-RADS Treatment Response Algorithm: Performance and Diagnostic Accuracy With Radiologic-Pathologic Explant Correlation in Patients With SBRT-Treated Hepatocellular Carcinoma.Int J Radiat Oncol Biol Phys2022
34800623Immunofluorescence Assay of Ablated Colorectal Liver Metastases: The Frozen Section of Image-Guided Tumor Ablation?J Vasc Interv Radiol2022
32302044MRI of the Pancreas.J Magn Reson Imaging2021
35531303Fibrolamellar Carcinoma.Appl Radiol2021
33786653Artificial intelligence in assessment of hepatocellular carcinoma treatment response.Abdom Radiol (NY)2021
33811482Phase 1b study of galunisertib and ramucirumab in patients with advanced hepatocellular carcinoma.Cancer Med2021
34902259Radiomics in surgical oncology: applications and challenges.Comput Assist Surg (Abingdon)2021
34491133Radiomics for CT Assessment of Vascular Contact in Pancreatic Adenocarcinoma.Radiology2021
34742159Impact of <sup>18</sup>F-Fluorodeoxyglucose positron emission tomography on management of cancer of unknown primary: systematic review and meta-analysis.Eur J Cancer2021
34621541Interactive Machine Learning-Based Multi-Label Segmentation of Solid Tumors and Organs.Appl Sci (Basel)2021
34559586Imaging Features at the Periphery: Hemodynamics, Pathophysiology, and Effect on LI-RADS Categorization.Radiographics2021
34503129Longitudinal Monitoring of Simulated Interstitial Fluid Pressure for Pancreatic Ductal Adenocarcinoma Patients Treated with Stereotactic Body Radiotherapy.Cancers (Basel)2021
34243925Evaluation of Hepatocellular Carcinoma Treatment Response After Locoregional Therapy.Magn Reson Imaging Clin N Am2021
34342503Patterns of Metastatic Disease in Patients with Cancer Derived from Natural Language Processing of Structured CT Radiology Reports over a 10-year Period.Radiology2021
34028593Correction to: Artificial intelligence in assessment of hepatocellular carcinoma treatment response.Abdom Radiol (NY)2021
34027566LI-RADS treatment response algorithm for detecting incomplete necrosis in hepatocellular carcinoma after locoregional treatment: a systematic review and meta-analysis using individual patient data.Abdom Radiol (NY)2021
34138636Quantitative Computed Tomography Image Analysis to Predict Pancreatic Neuroendocrine Tumor Grade.JCO Clin Cancer Inform2021
33226455Correction to: Evaluation of treatment response in hepatocellular carcinoma in the explanted liver with Liver Imaging Reporting and Data System version 2017.Eur Radiol2021
33109449Online Liver Imaging Course; Pivoting to Transform Radiology Education During the SARS-CoV-2 Pandemic.Acad Radiol2021
32986175Preoperative CT predictors of survival in patients with pancreatic ductal adenocarcinoma undergoing curative intent surgery.Abdom Radiol (NY)2021
32954446Differences in Liver Parenchyma are Measurable with CT Radiomics at Initial Colon Resection in Patients that Develop Hepatic Metastases from Stage II/III Colon Cancer.Ann Surg Oncol2021
  • 1 - 50 of 167

Recommended Authors

University of California los angeles
Career Start Year 2017
Number of shared co-authors 0
Department of Radiology Memorial Sloan Kettering Cancer Center
Career Start Year 2017
Number of shared co-authors 8
Stanford University School of Medicine
Career Start Year 2016
Number of shared co-authors 0
Johns Hopkins University School of Medicine
Career Start Year 2015
Number of shared co-authors 0
Sheba Medical Center
Career Start Year 2014
Number of shared co-authors 0
David Geffen School of Medicine, University of California at Los Angeles
Career Start Year 2012
Number of shared co-authors 0
Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus
Career Start Year 2010
Number of shared co-authors 3
Princess Margaret Cancer Centre
Career Start Year 2010
Number of shared co-authors 0
Peking University Cancer Hospital and Institute
Career Start Year 2008
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 2008
Number of shared co-authors 1
University of California san francisco
Career Start Year 2007
Number of shared co-authors 0
University of California san francisco
Career Start Year 2007
Number of shared co-authors 4
University of California san francisco
Career Start Year 2005
Number of shared co-authors 3
Duke University Medical Center
Career Start Year 2004
Number of shared co-authors 0
Gold Coast University Hospital
Career Start Year 2002
Number of shared co-authors 0
Goldman School of Medicine, Ben Gurion University
Career Start Year 2001
Number of shared co-authors 0
The Ohio State University College of Medicine
Career Start Year 2001
Number of shared co-authors 2
Dartmouth Hitchcock Medical Center
Career Start Year 1999
Number of shared co-authors 0
University of California, Los Angeles David Geffen School of Medicine
Career Start Year 1999
Number of shared co-authors 2
MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 1
National Cancer Institute, National Institutes of Health
Career Start Year 1995
Number of shared co-authors 4
University Health Network
Career Start Year 1995
Number of shared co-authors 5
Chinese PLA General Hospital
Career Start Year 1994
Number of shared co-authors 1
Cumming School of Medicine, University of Calgary
Career Start Year 1991
Number of shared co-authors 0
University of California, Los Angeles David Geffen School of Medicine
Career Start Year 1990
Number of shared co-authors 1
Clinical Center, National Institutes of Health
Career Start Year 1989
Number of shared co-authors 1
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1988
Number of shared co-authors 3
University of Colorado School of Medicine
Career Start Year 1983
Number of shared co-authors 3
National Cancer Institute, National Institutes of Health
Career Start Year 1982
Number of shared co-authors 1
University of California, Los Angeles David Geffen School of Medicine
Career Start Year 1973
Number of shared co-authors 0

Collaborators

Co-authored papers 45
Memorial Sloan-Kettering Cancer Center
Co-authored papers 6
Memorial Sloan Kettering Cancer Center
Co-authored papers 6
Mount Sinai Hospital
Co-authored papers 4
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
New York-Presbyterian Hospital/Weill Cornell Medicine
Co-authored papers 3
Memorial Sloan Kettering Cancer Center.
Co-authored papers 3
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Tisch Cancer Institute, Mount Sinai Hospital
Co-authored papers 3
Co-authored papers 3
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 2
Richards Medical Research Laboratories (S.B.)
Co-authored papers 2
Ottawa Hospital Research Institute Clinical Epidemiology Program
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 1
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Vanderbilt University
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Co-authored papers 1
Beth Israel Deaconess Medical Center, Harvard Medical School
Co-authored papers 1
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Mayo Clinic
Co-authored papers 1